Research Nester released a report titled “U.S. Non-Invasive Prenatal Testing Market: Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the U.S. non-invasive prenatal testing market in terms of market segmentation by product, by application, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Non-invasive prenatal testing is a screening method that involves determination of any chromosomal abnormalities in the fetus. The market for non-invasive prenatal testing in the United States is predicted to grow by a CAGR of 12.52% during the forecast period, i.e., 2020-2027. Further, the market is anticipated to reach USD 2,318.81 million by the end of this period. The substantial market growth can be attributed to the growing demand for prenatal testing, especially in the first and second trimester. The market is segmented by product, by application and by end user. The product segment is further segmented into Elisa kits, next generation sequencing systems and microarray analysis systems, out of which, the next generation sequencing systems segment is anticipated to hold the largest share in the market as a result of greater speed of sequencing and reduced cost of testing. By application, the market is segmented into aneuploidy, micro-deletion, trisomy and others, out of which, the trisomy segment is estimated to grow at the highest rate over the forecast period. This can be attributed to the growing use of non-invasive prenatal testing for detection of fetal trisomy. Further, on the basis of end user, the market is segmented into hospitals, diagnostic labs, clinics and others, out of which, the hospitals segment is estimated to hold the largest share in the market during this period on account of higher patient population and growing demand for improved treatments and diagnosis.
Click to Download Sample Report: https://www.researchnester.com/sample-request-1936
Growing Cases Of Chromosomal Abnormalities To Propel The Market Growth
According to the United Nations, approximately 3,000 to 5,000 children are born with Down syndrome every year. The chromosome 21 disorder has affected around 250,000 families in the United States. The rising number of incidences of chromosomal disorders such as the Down syndrome is a major factor estimated to drive the market growth. However, the strict government policies and inaccuracy of NIPT methods are predicted to restrict the market growth in the upcoming years.
This report also provides the existing competitive scenario of some of the key players of the U.S. non-invasive prenatal testing market which includes company profiling of Natera Inc., F. Hoffmann La Roche Ltd., Yourgene Health plc., Illumina, Inc., Agilent Technologies, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics and Myriad Genetics. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the U.S. non-invasive prenatal testing market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request for a sample of this research report @ https://www.researchnester.com/sample-request-1936
About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, the launch of new and advanced NIPT products, and increasing maternal age (growth in the risk of chromosomal abnormalities in babies).Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690What the Market Looks Like?Predicted to grow at a CAGR of 13.5% during the forecast period,the global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019.
The global Non Invasive Prenatal Testing (NIPT)Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
However, a dearth of skilled professionals is restraining the growth of this market.> By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.
The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period.> Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).> Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals.
In 2019, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products.Get Sample Copy of This Report@https://www.marketsandmarkets.com/requestsampleNew.asp?id=145607690What Drives the Market?The growth of the global market for Non Invasive Prenatal Testing (NIPT) is primarily influenced by the following factors:• High Risk of Chromosomal Abnormalities With Increasing Maternal Age• Growing Preference for Noninvasive Techniques Over Invasive Methods• Improving Reimbursement Scenario for NIPT• Programs Focusing on Increasing the Awareness of NIPTUntapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.
On the other hand, a dearth of skilled professionals is expected to restrain the growth of this market in the coming years.Geographical growth scenario of Non Invasive Prenatal Testing (NIPT) :Geographically, Non Invasive Prenatal Testing (NIPT) market has been studied for North America dominated the market, followed by Europe.
